|

Association of pembrolizumab + cabozantinib Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Institut Bergonié1

Indications

  • Undifferentiated Pleomorphic Sarcoma1
  • Advanced Soft-tissue Sarcoma1
  • Soft Tissue Sarcoma Adult1
  • Osteosarcoma1
  • Ewing Sarcoma1

Other1 trial

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.